Johnson & Johnson (NYSE:JNJ) has scheduled a conference call for 16th July 2020 at 8:00 AM Eastern Time to announce its 2Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.jnj.com
Earnings Expectation
Johnson & Johnson is set to announce second quarter earning results on Thursday 16th July 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, JNJ to report 2Q20 income of $ 1.48 per share. For the full year, analysts anticipate top line of $ 79535.50 million, while looking forward to income of $ 7.73 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 77,500.00 million ~ $ 80,500.00 million, where as bottomline are predicted in a range of $ 7.50 ~ $ 7.90 per share
Click Here For More Historical Outlooks Of Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSONS brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSONS Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand.
